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Objective: To evaluate the test characteristics of the urine dipstick as a screening tool for elevated 
serum creatinine in patients with uncontrolled diabetes mellitus in the emergency department (ED). 
Methods: Patients with diabetes over the age of 18 who presented to the ED for any complaint over 
a three-month study period were considered eligible for participation in this study. A finger-stick blood 
glucose of ≥250 mg/dL at triage was used to confirm the diagnosis of uncontrolled diabetes. After 
obtaining written consent, each patient had a urine dip performed and a chemistry panel drawn. Any 
level of proteinuria on the urine dip was considered to be a positive test. Based on the laboratory 
and clinical guidelines at our institution, renal insufficiency was defined as creatinine concentration 
of greater than 1.3 mg/dL. 
Results: Three Hundred ninety-three confirmed patients with uncontrolled diabetes were enrolled 
in this study, and 49 of these (12.5%) were found to have renal insufficiency. The sensitivity and 
specificity of the urine dip for predicting renal insufficiency were 69.4% (95% confidence interval [CI] 
54.6-81.7%) and 57.8% (95%CI 52.4-63.1%) respectively. The positive predictive value was 19% 
(95%CI 13.5-25.5%), and the negative predictive value was 93% (95%CI 88.7-96%). The positive 
likelihood ratio was 1.65 (95%CI 1.32-2.06) and the negative likelihood ratio was 0.53 (95%CI 0.34-
0.81).
Conclusion: In this cohort of patients with uncontrolled diabetes, the test characteristics of the 
urine dipstick make it a poor screening tool for renal insufficiency in the ED. [West J Emerg Med. 
2011;12(2):250-253.]
INTRODUCTION
Diabetes mellitus is the foremost cause of end-stage renal 
disease in the United States.1 Diabetes-specific changes in 
blood flow in the kidney stemming from glomerulosclerosis 
put poorly controlled patients with diabetes at high risk for 
clinically significant nephropathy.2 As such, the threshold to 
screen patients who present in the emergency department (ED) 
with uncontrolled diabetes for renal dysfunction has always 
been low. In addition, the added fear of contrast-induced 
nephropathy has led to routine serum creatinine screening in 
most patients with diabetes prior to contrast enhanced 
computed tomography.3 As the prevalence of patients with 
diabetes seen in the ED continues to rise, a rapid way to 
screen for renal dysfunction becomes increasingly important. 
The urine dipstick is commonly used in EDs to look for 
white blood cells and other markers of urinary tract infections; 
to check for red blood cells in patients with suspected renal 
stones; and to detect ketones in patients with diabetes who 
are suspected of being in diabetic ketoacidosis (DKA). The 
dipstick test has the advantages of being inexpensive, quick 
and noninvasive. Because of these advantages, investigators 
have examined the urine dipstick’s usefulness as a screening 
tool for renal insufficiency with hopes of obviating the 
need for serum creatinine testing. The urine dipstick has 
previously been evaluated as a routine screening test for both 
renal and cardiovascular disease in an outpatient setting.4,5 
These studies of outpatients with and without risk factors for 
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contrast, studies that included only specific, high-risk patient 
populations, such as hypertensive patients, have shown much 
more promise for expanding the role of the urine dipstick as 
a screening tool for renal insufficiency.6 Therefore, we sought 
to evaluate the test characteristics of the urine dipstick as a 
screening tool for elevated serum creatinine in patients with 
known or newly diagnosed diabetes and random blood sugar > 
250 mg/dl.  
METHODS
The institutional review board of the Los Angeles County 
Hospital at University of Southern California (LAC+USC) 
approved this prospective study, and we obtained written 
informed consent from all study participants. The cohort 
studied represents a convenience sample of ED patients 
presenting between the hours of 9am and 5pm from October 
2007 to December 2007. All adult patients with known or 
suspected diabetes who presented to ED triage for any reason 
were screened for enrollment. Obtaining a blood glucose value 
at triage was at the discretion of the triage nurse and was not a 
formal part of the study protocol. Only those patients with 
blood glucose at triage of at least 250 mg/dL were considered 
eligible for enrollment. This value was chosen as it is a 
generally accepted tipping point endorsed by the American 
Diabetes Association at which many triage protocols and 
practicing emergency physicians initiate a laboratory workup 
looking for evidence of acute and chronic ailments (i.e. renal 
dysfunction, DKA, infection).7 Subjects were excluded if they 
were judged as not being in a mental and/or physical state to 
provide informed consent. 
All enrolled patients had both a urine dipstick (Bayer 
multistix 10SG) performed to look for protein, and a blood 
draw to assess serum creatinine. Any level of proteinuria on 
the urine dip was considered to be a positive test, and per the 
manufacturer the cutoff value is 20 mg/L. We did not record 
the exact level of proteinuria. Renal insufficiency was defined 
as serum creatinine concentration of greater than 1.3 mg/dL. 
This value is based on the laboratory and clinical guidelines 
at our institution for renal dysfunction. The urine dipstick was 
read by the treating nurse and relayed to a research assistant 
in real time. We analyzed data using STATA version 9.0. 
Sensitivity, specificity, predictive values, likelihood ratios and 
corresponding confidence intervals were determined for the 
urine dip using the ‘diagt’ command.
RESULTS
Of 513 patients with uncontrolled diabetes identified 
in ED triage in the three-month study period, 393 agreed to 
participate. Characteristics of the sample are given in Table 
1. Forty-nine (12.5%) had renal insufficiency defined as a 
serum creatinine level of greater than 1.3 mg/dL. The urine 
dip was positive for proteinuria in 179 (45.5%) patients. The 
urine dipstick was 69.4% sensitive (95% confidence interval 
[CI], 54.6-81.7%) and 57.8% specific (95% CI, 52.4-63.1%) 
in this sample (Table 2). The positive predictive value of the 
urine dip was 19% (95% CI, 13.5-25.5%) and the negative 
predictive value was 93% (95% CI, 88.7-96%). The positive 
likelihood ratio was 1.65 (95% CI, 1.32-2.06) and the negative 
likelihood ratio was 0.53 (95% CI, 0.34-0.81).
DISCUSSION
The urine dipstick is a rapid, noninvasive and inexpensive 
means of screening patients during ED triage for a variety of 
potential disease states. This has prompted clinician scientists 
to attempt to expand its usefulness by studying its ability to 
screen for renal insufficiency. Although results from prior 
studies are varied, some believe it is possible that the urine dip 
may be more reliable if used as a screening tool for renal 
dysfunction in a more specific and well-defined patient 
population.6
Glauser et al8 performed a retrospective study examining 
whether urine protein could replace serum creatinine as a 
rapid screening test for renal dysfunction in patients 
considered to be at low risk for renal disease. They defined 
their low risk cohort by the absence of hypertension, diabetes 
mellitus, multiple myeloma and systemic lupus erythematosus. 
They retrospectively identified 310 patients who met their 
low-risk criteria and had a serum creatinine level and negative 
urine protein assessment based on chart review. They found 
that none of the patients in their cohort had an elevated 
creatinine level. This study was limited by a high cutoff for 
Table	1.	Demographic information of enrolled patients.
Age Mean 47.7 +/- 12.5
Gender Male: 67%
Female: 33%
Insulin dependent Yes: 47%
No: 53%
Ethnicity Hispanic: 78%
African American: 15%
Asian: 3%
Caucasian: 2%
Other: 2%
Table	2.	Test characteristics of urine dipstick in detecting abnor-
mal creatinine in emergency department patients with out-of-
control diabetes.
Test Value 95%	Confidence	Interval
Sensitivity 69.4 54.6-81.7
Specificity 57.8 52.4-63.1
Positive predictive value 19 13.5-25.5
Negative predictive value 93 88.7-96
Positive likelihood ratio 1.65 1.32-2.06
Negative likelihood ratio 0.53 0.34-0.81
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renal insufficiency (greater than 2.0 mg/dL) and by the fact 
that not all patients with a negative urine protein truly received 
the gold standard test for renal dysfunction. 
Firestone et al9 conducted a retrospective chart review 
examining the utility of urine dipstick as a screening tool in 
ED patients. Their goal was to identify a set of risk factors 
whose absence, combined with a negative urine dip, could rule 
out renal dysfunction. After a review of over 2400 charts, they 
concluded that in isolation, the sensitivity and negative 
predictive value of the urine dip in detecting renal 
insufficiency were 85.5% and 96.2% respectively. All patients 
with elevated creatinine were found to have at least one of the 
following high-risk conditions: prior renal disease, 
hypertension, diabetes, congestive heart failure or age >60. 
The authors conclude that the sensitivity of the urine dip was 
inadequate to merit its use as a stand-alone test, but if 
combined with a clinical questionnaire adequate sensitivity 
may be reached.
Subsequently, Firestone et al10 prospectively collected 
data on 1,354 ED patients, including urine dipstick results, 
triage vital signs, basic demographic data, 14 medical history 
items and serum creatinine results. Through logistic regression 
they identified the following predictor variables associated 
with elevated creatinine: age >60 years, known renal 
insufficiency, diabetes, hypertension, diuretic use, vomiting, 
and proteinuria. They concluded a negative urine dipstick 
combined with the absence of the aforementioned risk factors 
result in a dipstick sensitivity of 98.1% (95.8-99.9%) and a 
specificity of 21.2% (18.8-23.2%).
Given the success of the urine dip in screening for 
renal insufficiency in a very well-defined, low-risk group of 
patients, we sought to determine if it could be used to screen 
for renal insufficiency in a well-defined, high-risk group of 
patients. After considering all potential predictor variables 
and chronic diseases, we chose to examine the utility of the 
urine dipstick for detecting elevated creatinine levels in ED 
patients with uncontrolled diabetes. We chose this group 
based on the high prevalence of disease among ED patients, 
as well as the severity of disease specific and iatrogenic (i.e. 
contrast-induced nephropathy) renal dysfunction in this group. 
Unfortunately, our results show that in this high-risk group of 
ED patients with uncontrolled diabetes, the poor calculated 
test characteristics do not make the urine dipstick a viable 
screening tool for elevated creatinine levels.
LIMITATIONS
When designing this prospective trial we worked to 
minimize bias and other sources of potential error; however, 
some limitations warrant mentioning. First, the interpretation 
of dipstick results is somewhat subjective, and as all nurses 
have their clinical laboratory improvement amendments 
(CLIA) certification, we did not offer additional training to the 
nurses who interpreted the urine dips, nor did we have 
multiple staff members read the same dipstick to ensure that 
we had adequate inter-rater reliability. That being said, the 
health professionals responsible for interpreting and recording 
the urine dip results are already very familiar and comfortable 
with this process and do this daily as part of their daily clinical 
care. Also, subjectivity exists in assigning an exact level to a 
positive test and significantly less existing in purely 
distinguishing positive from negative. The staff reading the 
dipsticks was not blinded to the purpose of the study, but this 
too was unnecessary as the creatinine value was not obtained 
until a later point in each patient’s ED workup.
Second, the glomerular filtration rate, and not an elevated 
serum creatinine, is truly the gold standard for renal 
dysfunction. We chose to use serum creatinine as a surrogate 
for renal function in our study because in the ED this is the 
measurement used in clinical decision-making, and it is much 
easier to obtain and more commonly used in prior studies on 
the same topic. As such, although imperfect, the serum 
creatinine seems to be the most appropriate reference standard 
for our purposes. We defined renal dysfunction as a serum 
creatinine concentration of greater than 1.3 mg/dL. Other 
published studies have used differing values (i.g. 1.5 or 2.0 
mg/dL) based on what the laboratories at their specific 
institutions consider to be abnormal. Our value was chosen 
after a discussion with the clinical laboratory at our hospital. If 
we had used either a value of 1.5 or 2.0 mg/dl the sensitivity 
and specificity still do not reach acceptable values. 
(Sensitivities 67.6%, 95%CI 50.2-82% and 71.4%, 95%CI 
41.9-91.6% respectively; specificities 56.7%, 95%CI 51.4-
62% and 55.4%, 95%CI 50.2-60.5% respectively).
Third, we did not screen the patients in our study for co-
occurring diseases that might have affected the urine dipstick 
results. We knew the enrolled patients were at high risk for 
renal disease based on their uncontrolled diabetes, which 
could affect their level of proteinuria. Had we also recorded 
the presence or absence of other high-risk diseases identified 
in previous studies we could have attempted to evaluate 
test characteristics of the urine dipstick in combination with 
other high-risk disease states (i.e. patients with diabetes and 
hypertension). However, it seemed to be reasonable to start 
with just one condition. Finally, this study was conducted at a 
single urban ED with a largely Latino patient population and 
thus has limited external generalizibility.
CONCLUSION
Our study contributes to the growing knowledge base 
concerning the use of the urine dip by offering data from the 
specific high-risk population of patients with diabetes. We 
found in our cohort of patients with uncontrolled diabetes, 
the urine dipstick had a sensitivity of 68.6% (95% CI, 49.9-
83.2%) and a specificity of 55.2% (95% CI, 48.4-62.0%) 
in screening for renal insufficiency. Our results suggest 
that dipstick analysis should not be used as a stand-alone 
screening test for renal insufficiency and cannot be used as a 
replacement for obtaining a serum creatinine in patients with 
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diabetes. Further study is warranted to confirm these findings 
in a broader array of clinical settings.
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